Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at UBS Conference

UBS Global Life Sciences Conference

ROCKVILLE, Md.--()--Human Genome Sciences, Inc. (NASDAQ: HGSI) announced today that its presentation at the UBS Global Life Sciences Conference will be webcast and may be accessed at www.hgsi.com.

A member of Human Genome Sciences’ senior management team will present a corporate overview on Wednesday, September 21, 2011, at 11:30 AM Eastern time. Investors interested in listening to the live webcast should log on before the start time in order to download any software required. The archive of the webcast will be available for several days after the live event.

ABOUT HUMAN GENOME SCIENCES

Human Genome Sciences exists to place new therapies into the hands of those battling serious disease.

For more information about HGS, please visit the Company’s web site at www.hgsi.com. Health professionals and patients interested in clinical trials of HGS products may inquire via e-mail to medinfo@hgsi.com or by calling HGS at (877) 822-8472.

HGS and Human Genome Sciences are trademarks of Human Genome Sciences, Inc. Other trademarks referenced are the property of their respective owners.

Contacts

For Human Genome Sciences, Inc.
Media:
Susannah Budington, 301-545-1062
Director, Corporate Public Relations
or
Jerry Parrott, 301-315-2777
Vice President, Corporate Communications
or
Investors:
Claudine Prowse, Ph.D., 301-315-1785
Executive Director, Investor Relations
or
Peter Vozzo, 301-251-6003
Senior Director, Investor Relations

Contacts

For Human Genome Sciences, Inc.
Media:
Susannah Budington, 301-545-1062
Director, Corporate Public Relations
or
Jerry Parrott, 301-315-2777
Vice President, Corporate Communications
or
Investors:
Claudine Prowse, Ph.D., 301-315-1785
Executive Director, Investor Relations
or
Peter Vozzo, 301-251-6003
Senior Director, Investor Relations